# Open-labelled Study to Evaluate the Effect of SE5-OH Tablets on Healthy Women With Menopausal Symptoms

> **NCT06398236** · NA · COMPLETED · sponsor: **Nutrition & Sante Iberia** · enrollment: 170 (actual)

## Conditions studied

- Menopause

## Interventions

- **DIETARY_SUPPLEMENT:** SE5-OH tablets

## Key facts

- **NCT ID:** NCT06398236
- **Lead sponsor:** Nutrition & Sante Iberia
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-17
- **Primary completion:** 2024-07-18
- **Final completion:** 2024-10-16
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2025-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06398236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06398236, "Open-labelled Study to Evaluate the Effect of SE5-OH Tablets on Healthy Women With Menopausal Symptoms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06398236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*